In prostate cancer cells, bombesin(BBS) induced IκB degradation and activated NF-κB, resulting in increased IL-8 and VEGF mRNA expression and stronger migration of HUVECs in vitro (101). Here, NFKB1 is linked to prostate carcinoma.